Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587769 | SCV000699998 | benign | not provided | 2017-07-21 | criteria provided, single submitter | clinical testing | Variant summary: The PCSK9 c.525C>T (p.Asp175Asp) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may abrogate the binding sites for splicing enhancers. However, these predictions have yet to be confirmed by functional studies. The variant of interest has been found in a large, broad control population, ExAC in 44/121334 control chromosomes at a frequency of 0.0003626, which is approximately 4 times the estimated maximal expected allele frequency of a pathogenic PCSK9 variant (0.0000938), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. |
Invitae | RCV001087468 | SCV000766244 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776138 | SCV000911125 | benign | Familial hypercholesterolemia | 2018-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000587769 | SCV000969265 | likely benign | not provided | 2020-09-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25904937) |
Illumina Laboratory Services, |
RCV001099139 | SCV001255562 | likely benign | Hypobetalipoproteinemia | 2017-10-29 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001087468 | SCV001255563 | benign | Hypercholesterolemia, autosomal dominant, 3 | 2017-10-29 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000587769 | SCV002046349 | benign | not provided | 2020-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341511 | SCV002643834 | likely benign | Cardiovascular phenotype | 2018-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000587769 | SCV004564203 | benign | not provided | 2023-09-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004543307 | SCV004771173 | likely benign | PCSK9-related disorder | 2020-01-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000587769 | SCV001917783 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000587769 | SCV001962839 | likely benign | not provided | no assertion criteria provided | clinical testing |